Suchergebnisse - (Person:"Jimenez-Fonseca, Paula")

PubPharm (10)

1

Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Arias-Martinez, A. | Martínez de Castro, E. | Gallego, J. | +28

2

Prospective Study Comparing Clinicians' and Cancer Patients' Estimates of Risk of Relapse and Toxicity with Adjuvant Chemotherapy

enthalten in: Cancer investigation | 2021

von Calderon, C. | Jiménez-Fonseca, P. | Hernández, R. | +7

3

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2021

von Alvarez-Manceñido, F. | Jimenez-Fonseca, P. | Carmona-Bayonas, A. | +31

4

Impact of Obesity on Quality of Life, Psychological Distress, and Coping on Patients with Colon Cancer

enthalten in: The oncologist | 2021

von Gomez, D. | Jimenez-Fonseca, P. | Fernández, A. | +9

5

External validity of docetaxel triplet trials in advanced gastric cancer : are there patients who still benefit?

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2021

von Jimenez-Fonseca, P. | Carmona-Bayonas, A. | Martínez de Castro, E. | +31

6

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

enthalten in: Gastric cancer | 2021

von Alvarez-Manceñido, F. | Jimenez-Fonseca, P. | Carmona-Bayonas, A. | +31

7

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

enthalten in: Gastric cancer | 2021

von Alvarez-Manceñido, F. | Jimenez-Fonseca, P. | Carmona-Bayonas, A. | +31

8

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

enthalten in: Gastric cancer | 2020

von Jimenez-Fonseca, P. | Carmona-Bayonas, A. | Martínez de Castro, E. | +31

9

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

enthalten in: Gastric cancer | 2020

von Jimenez-Fonseca, P. | Carmona-Bayonas, A. | Martínez de Castro, E. | +31

10

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

enthalten in: Gastric Cancer | 2020

von Jimenez-Fonseca, P. | Carmona-Bayonas, A. | Martínez de Castro, E. | +31

1
[1]